SP-MHCI-1297-2

Alpha-enolase 326-340, KRIAKAVNEKSCNCL

US$169.00

In stock

Description

About Alpha-enolase 326-340, KRIAKAVNEKSCNCL

The Human Alpha-enolase Peptide (IEDB: 227794) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Alpha-enolase Peptide, H-KRIAKAVNEKSCNCL-OH (Uniprot: P06733 aa: 326-340) from JPT is produced under strict quality control and quality management.

Alpha-enolase 326-340, KRIAKAVNEKSCNCL - Specifications

  • Peptide sequence: H-KRIAKAVNEKSCNCL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Diabetes
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Alpha-enolase 326-340, KRIAKAVNEKSCNCL

References:
Read References with JPT’s Antigen Peptides

Alpha-enolase 326-340, KRIAKAVNEKSCNCL has been described in:
Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy., Arthritis Rheumatol, 2014 (PMID: 24665079.0)
Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis., Front Immunol, 2016 (PMID: 27895642.0)
Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint., J Autoimmun, 2018 (PMID: 29853344.0)

Documentation

Documentation for Alpha-enolase 326-340, KRIAKAVNEKSCNCL

Properties

Properties of Alpha-enolase 326-340, KRIAKAVNEKSCNCL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Diabetes
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to Alpha-enolase 326-340, KRIAKAVNEKSCNCL

Information Values
Sequence: H-KRIAKAVNEKSCNCL-OH
Specifications: 15mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote